Kovai Medical Center & Hospital logo

Kovai Medical Center & Hospital financials and balance sheet

NSE: KOVAIBSE: 523323Healthcare ServicesSmall Cap

Last close ₹5,757.50down ₹49.00 (0.84%)BSE ₹5,737.95

Share price at the NSE close on 23 Oct 2026. Previous close ₹5,806.50.

52-week range of BSE trades to 23 Oct 2026
₹5,010.00Low, 30 Mar 2026₹6,725.00High, 27 Oct 2025
Market cap
₹6,300 Cr728th largest listed
P/E
24.6
P/B
4.8
Dividend yield
0.26%
ROE
21.3%
ROCE
20.3%
Debt to equity
0.28
Volume, NSE
9,44061.4% delivered

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Kovai Medical Center & Hospital annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹1,586 Cr, year to Mar 2026

Operating and net margin, per cent

  • Operating margin
  • Net margin

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out. Lease payments were 0.6% of operating profit in the first full year.

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue1,586
  2. Materials and goods−448
  3. Employee costs−306
  4. Other expenses−392
  5. Operating profit439
  6. Depreciation−109
  7. Other income+28
  8. One-off items0.0
  9. Finance costs−32
  10. Profit before tax326
  11. Tax−81
  12. Net profit244

What the company owns

  • Plant, investments and other assets₹1,661 Cr
  • Cash and bank₹347 Cr
  • Receivables₹38 Cr
  • Inventory₹20 Cr

What pays for it: net worth and liabilities

  • Net worth₹1,319 Cr
  • Borrowings₹369 Cr
  • Other liabilities₹353 Cr
  • Owed to suppliers₹24 Cr

Kovai Medical Center & Hospital business segments, year to Mar 2026

A reportable segment is a line of business the company must report on its own. Standalone, ₹ crore, as the company reports them.Kovai Medical Center & Hospital segment results by quarter

Revenue by segment

₹1,586 CrTotal
  • Healthcare₹1,470 Cr92.7% of total
  • Education₹115 Cr7.3% of total

Profit by segment

  • Healthcare₹338 Cr86.7% of total
  • Education₹52 Cr13.3% of total

Segment results by year

Standalone, ₹ crore, years to March.

  • Healthcare

    Revenue, ₹ crore
    Profit, ₹ crore
  • Education

    Revenue, ₹ crore
    Profit, ₹ crore
₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue of all businesses–7126909061,0201,2201,3711,586
Company revenue, as in its results6287126909061,0191,2201,3711,586
Revenue–6976688789531,1261,2791,470
Revenue growth––−4.1%31.3%8.6%18.2%13.6%15.0%
Profit–284138191186248305338
Profit growth––−51.3%38.0%−2.4%33.0%23.1%10.6%
Margin–40.8%20.7%21.8%19.6%22.0%23.9%23.0%
Return on capital–93.0%39.1%12.6%30.9%36.4%33.4%29.9%
Assets–7939569641,1081,0451,4331,752
Liabilities–488601−554504364519621
Capital employed–3053541,5186036829141,131
Revenue–152228679493115
Profit is before tax and finance costs, the way companies report their segments.

Profit and loss

Standalone, ₹ crore, years to March.Kovai Medical Center & Hospital quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 29 MayMar 2020Filed 20 JunMar 2021Filed 4 JunMar 2022Filed 9 JunMar 2023Filed 30 MayMar 2024Filed 11 JunMar 2025Filed 13 JunMar 2026Filed 25 May
Revenue from operations5265926287126909061,0191,2201,3711,586
4034644955444976487518789851,147
Materials and goods bought88–187205194256283324368448
Employee costs––111125119151180219251306
Other expenses––197214185241289335366392
Operating profit before depreciation123129132168193258267342386439
Operating margin23.3%21.7%21.1%23.6%28.0%28.4%26.2%28.0%28.1%27.7%
Materials, % of revenue––29.9%28.8%28.0%28.3%27.8%26.6%26.9%28.3%
Employee costs, % of revenue––17.7%17.5%17.2%16.6%17.6%18.0%18.3%19.3%
Other expenses, % of revenue––31.4%30.1%26.8%26.7%28.3%27.4%26.7%24.7%
Depreciation and amortisation243436526885899298109
Operating profit after depreciation999597116125172178250288329
Other income88811121217212228
Finance costs15131215314340333332
One-off items––00000000
Profit before tax928993112106141155238278326
32313317283639586981
Net profit6058609578104116180209244
Other comprehensive income––011−21100
Total comprehensive income––609679103116180209244
Net margin11.4%9.8%9.6%13.3%11.3%11.5%11.4%14.7%15.2%15.4%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the years to Mar 2017 and Mar 2018 they do not, so they are left blank.
Earlier years, Mar 2008 to Mar 2016
₹ croreMar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Revenue from operations88111130175222297334402465
–92105139179227261–374
Materials and goods bought29184259–––––
Operating profit before depreciation–192536447073–92
Operating margin–17.2%19.3%20.7%19.7%23.6%21.8%–19.7%
Depreciation and amortisation–457121516–21
Operating profit after depreciation–152130325657–71
Other income102123578
Finance costs245111727242017
Profit before tax81117201631375962
Tax3467410142122
Net profit5712121221243940
Net margin6.0%6.4%8.9%6.9%5.4%7.2%7.1%9.6%8.7%
Standalone, ₹ crore, years to March.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Filed 29 MayMar 2020Filed 20 JunMar 2021Filed 4 JunMar 2022Filed 9 JunMar 2023Filed 30 MayMar 2024Filed 11 JunMar 2025Filed 13 JunMar 2026Filed 25 May
3434315106097198891,0861,319
Share capital1111111111111111
Reserves3324204995987088781,0751,308
345508559511473274382369
121105138163185205270327
385571633570538345444420
Total assets8501,1071,2811,3431,4421,4381,8002,066
7209651,0931,1051,1431,1881,4691,645
129142188238299250331421
Net debt2443954043132246310822
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Filed 4 JunMar 2022Filed 9 JunMar 2023Filed 30 MayMar 2024Filed 11 JunMar 2025Filed 13 JunMar 2026Filed 25 May
186263263344353362
208301300401414446
43216416−1
Receivables−2−4−27000
Payables−10826000
Other working capital162717416−1
Tax paid−22−39−37−57−61−84
Capital spending18199127138353252
Free cash flow51631362060110
−180−99−127−138−352−230
38−120−86−24362−58
Dividends paid037111111
Shares bought back000000
Shares issued000000
Net change in cash444450−386373
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.Kovai Medical Center & Hospital dividend history

₹ per shareMar 2017Mar 2018Mar 2019Filed 29 MayMar 2020Filed 20 JunMar 2021Filed 4 JunMar 2022Filed 9 JunMar 2023Filed 30 MayMar 2024Filed 11 JunMar 2025Filed 13 JunMar 2026Filed 25 May
Earnings per share₹54.64₹52.98₹54.96₹86.44₹71.00₹95.28₹105.80₹164.25₹190.95₹223.41
Diluted earnings per share₹54.64₹52.98₹54.96₹86.44₹71.00₹95.28₹105.80₹164.25₹190.95₹223.41
Dividend per share₹2.50₹3.00₹3.00₹3.00₹3.00₹6.00₹10.00₹10.00₹10.00₹15.00
Book value per share––₹313.69₹393.92₹466.08₹556.84₹657.12₹812.02₹992.63₹1,205.66
Dividend payout4.6%5.7%5.5%3.5%4.2%6.3%9.5%6.1%5.2%6.7%
Shareholder yield––––0.0%0.2%0.3%0.3%0.2%0.2%
Market cap at the year end (₹ crore)1,4391,3698447441,2071,7422,0204,0945,6695,496
RatioMar 2017Mar 2018Mar 2019Filed 29 MayMar 2020Filed 20 JunMar 2021Filed 4 JunMar 2022Filed 9 JunMar 2023Filed 30 MayMar 2024Filed 11 JunMar 2025Filed 13 JunMar 2026Filed 25 May
Revenue growth13.0%12.7%6.0%13.4%−3.0%31.2%12.4%19.7%12.4%15.6%
Operating profit growth33.6%5.1%2.7%27.0%15.0%33.3%3.8%27.8%12.9%13.8%
Net profit growth47.9%−3.0%3.7%57.3%−17.9%34.2%11.0%55.3%16.3%17.0%
Earnings per share growth–−3.0%3.7%57.3%−17.9%34.2%11.0%55.2%16.3%17.0%
––17.5%24.4%16.5%18.6%17.4%22.4%21.2%20.3%
–––6.9 pts−7.9 pts2.1 pts−1.2 pts4.9 pts−1.2 pts−0.8 pts
From the net margin–––6.8 pts−3.7 pts0.4 pts−0.2 pts5.2 pts0.8 pts0.2 pts
From asset turnover–––−0.4 pts−4.2 pts3.3 pts1.1 pts3.6 pts0.0 pts−0.7 pts
From borrowing–––0.5 pts0.1 pts−1.5 pts−2.1 pts−3.8 pts−2.0 pts−0.4 pts
Return on capital employed––14.1%12.3%11.7%15.4%14.9%21.5%19.6%19.5%
Cash conversion––––239.9%251.8%227.1%191.5%168.9%148.0%
Interest cover6.77.47.97.94.04.04.47.68.810.3
Debt to equity––1.011.181.100.840.660.310.350.28
Receivable days––64689589
Inventory days––2023191818171516
Payable days––4746292035302920
Cash conversion cycle, days––−21−19−45−9−8−65
Working capital days––−49−37−51−38−39−43−48−46
Asset turnover––0.740.730.580.690.730.850.850.82
Assets per rupee of net worth––2.482.532.542.342.101.791.641.61
Sales per rupee of plant––1.341.160.690.860.941.091.071.08
Capital spending to depreciation––––2.661.161.431.503.622.30
Plant being built, % of plant in use––48.5%48.8%4.6%0.5%2.1%3.5%11.7%9.2%
No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
12.6%
Cash from operations against operating profit
82.4%
Measure10 years5 years3 years
Revenue growth, yearly rate13.0%18.1%15.9%
Profit growth, yearly rate19.7%25.8%28.3%
Return on equity, average–20.0%21.3%
Return on capital employed, average–18.2%20.2%
Operating margin, average25.6%27.7%27.9%
Net margin, average12.4%13.7%15.1%
Asset turnover, average–0.790.84
Cash conversion cycle, days, average–−2−3
Interest cover, average6.97.08.9
Debt to equity, average–0.490.31

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations1,5841,059362
Cash from investing−946−720−230
Cash from financing−445−240−58
Capital spending970743252
Dividends paid423311
Shares bought back000
Shares issued for cash000
Borrowings raised–00
Borrowings repaid31931913

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––789876
Altman Z-scorePublished threshold 1.812.712.252.423.243.616.836.976.70
Beneish M-scorePublished threshold −1.78––−2.90−2.56−2.70−3.06−1.72−2.58
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––6.01−4.51−1.46−1.8212.865.84
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––2.392.181.901.67
Receivables growth less revenue growthOur threshold 0 percentage points–−29.2228.0752.5018.18−53.2571.067.85
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–15.65−13.74−9.43−1.23−7.41−7.518.06
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–0.150.64−0.520.34−0.290.170.33
Assets under construction, years of additionsOur threshold 2 years of additions–1.520.100.040.180.320.570.46
Effective tax ratePublished threshold 17.16 per cent35.2215.4826.5325.8925.4224.3424.7224.94
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––−1.561.390.302.75−0.84
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
26 Sep 2025CRISIL Ratings Limited (opens in a new tab)Bank FacilitiesLong-term scaleCrisil AA-Rating ReaffirmedStable140.90
26 Sep 2025CRISIL Ratings Limited (opens in a new tab)Bank FacilitiesLong-term scaleCrisil AA-Rating ReaffirmedStable100
26 Sep 2025CRISIL Ratings Limited (opens in a new tab)Bank FacilitiesLong-term scaleCrisil AA-Rating ReaffirmedStable50
26 Sep 2025CRISIL Ratings Limited (opens in a new tab)Bank FacilitiesShort-term scaleCrisil A1+Rating Reaffirmed100
26 Sep 2025CRISIL Ratings Limited (opens in a new tab)Bank FacilitiesCrisil AA-Review, Re-affirmStable350
26 Sep 2025CRISIL Ratings Limited (opens in a new tab)Bank FacilitiesLong-term scaleCrisil AA-Rating ReaffirmedStable9.15
26 Sep 2025CRISIL Ratings Limited (opens in a new tab)Bank FacilitiesLong-term scaleCrisil AA-Rating ReaffirmedStable119.95
26 Sep 2025CRISIL Ratings Limited (opens in a new tab)Bank FacilitiesCrisil A1+Review, Re-affirm15
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.